Skip to content
TrialScanner

NCT06559163

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Phase 2Active, not recruitingZBIOLead

Registry record

Lead sponsor
Zenas BioPharma (USA), LLC
Conditions
Systemic Lupus Erythematosus
Primary completion
Sep 23, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06559163 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

1 change recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06559163: A Study of Obexelimab in... | TrialScanner